Delivery Order SPE2DB22D1017-SPE2DB23FF9KA
Award Date 7/3/23
Potential Completion Date 7/5/23
Potential Value $11K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Actemra 162 mg/0.9 mL syringes valued at $11,411.43 under a firm fixed-price contract. The delivery order is non-set-aside and carries an ultimate completion date of September 4, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $5,198.08 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division to supply 4561391614 ACTEMRA 162 MG/0.9 ML SYRINGES. The syringes will be delivered to a location in Conshohocken, Pennsylvania between June 30 and July 3, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support of the United States Department of Defense, this delivery order was likely placed to supply pharmaceutical products in...
- The Defense Logistics Agency awarded a $15,594 delivery order to Amerisourcebergen Drug Corporation for 162 mg/0.9 ml syringes of Actemra. The prime contractor will deliver the pharmaceutical product from its Conshohocken, Pennsylvania facility to support Department of Defense requirements. The firm fixed price order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and has a period of performance concluding on July 31, 2023. No subcontractors or set-aside designations...
- The Defense Logistics Agency awarded a $18,443.95 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 162 milligram/0.9 milliliter syringes of Actemra. Actemra is a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The place of performance for the delivery order is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is brief, spanning just one day from September 19, 2023 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Actemra 162 mg/0.9 mL syringes valued at $19,277.63. This is a firm fixed-price delivery order with an ultimate completion date of November 14, 2025, and represents performance at the vendor's location in Conshohocken, Pennsylvania. The award was made through competitive procurement with no set-aside designation, demonstrating AmerisourceBergen's capability to compete...
- The Defense Logistics Agency awarded a $11,519.73 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 162 milligrams per 0.9 milliliter syringes of Actemra. Actemra is a brand name biologic medication used to treat conditions such as rheumatoid arthritis. The place of performance for this contract is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 23, 2023 through August 24, 2023. No major...
- The Defense Logistics Agency Troop Support Medical awarded a $5,198.08 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 162 mg/0.9 ml syringes of Actemra. Place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between July 26-27, 2023. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen will fulfill this order to supply the prescription medication Actemra, used to treat rheumatoid...
- The Defense Logistics Agency awarded a $4,822.16 delivery order to AmerisourceBergen Drug Corp for Actemra 162 mg/0.9 mL syringes on November 18, 2025, with completion scheduled for November 19, 2025. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.9 billion prime vendor agreement designated SPE2DX and running through December 2026. The award carries no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $7,194.60 to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed price delivery order, which was competitively awarded without set-aside designation, will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. Actemra is a biologic immunosuppressant medication commonly used in the treatment...
- The Defense Logistics Agency awarded a delivery order valued at $32,313.93 to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes. This firm fixed-price contract, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a non-set-aside competitive award. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery...